Welcome to the International AIDS Society-USA

Publications/Guidelines

Topics in HIV Medicine®
2002 ISSUES

November/December 2002 Issue (Volume 10, Issue 5)
Download the entire issue here or select individual articles below.

Perspectives

Initial Antiretroviral Therapy: When and With What to Begin
Donna E. Sweet, MD
HIV Drug Resistance: Implications for Management
Scott M. Hammer, MD
HIV Infection in Women: Selected Issues in Pregnancy
Judith S. Currier, MD
The Changing Nature of the Prevention and Management of Opportunistic Infections
Henry Masur, MD
Depression and Adjustment Disorder in Patients With HIV Disease
Andrew F. Angelino, MD

Special Contribution:

Drug Resistance Mutations in HIV-1
International AIDS Society–USA Drug Resistance Mutations Group

September/October Issue 2002 (Volume 10, Issue 4)
Download the entire issue here or select individual articles below.

Perspectives

Insights in HIV Pathogenesis and Antiviral Control
H. Clifford Lane, MD
HIV Vaccine Research: Problems and Progress
Richard A. Koup, MD
Current Status of New Antiretroviral Drugs in Development
Roy M. Gulick, MD, MPH

Reprint:

Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society–USA Panel.
JAMA. 2002;288:222-235.
Available at http://www.iasusa.org/pub/arv_2002.pdf.

Announcements:

World Health Organization Guidelines for Scaling Up Antiretroviral Therapy in Resource-Limited Settings

July/August 2002 Issue (Volume 10, Issue 3)
Download the entire issue here or select individual articles below.

Perspectives

Viral Binding and Fusion—The Next Targets in Antiretroviral Therapy
Eric Hunter, PhD
Where Do Strategic Treatment Interruptions Fit in the Management of HIV Infection?
W. Keith Henry, MD

Special Contributions:

Current Strategies for Antiretroviral Therapy: Panel Discussion of Clinical Cases
Michael S. Saag, MD, and Jeffrey L. Lennox, MD
HIV in India
Suniti Solomon, MD, and Aylur Kailasam Ganesh, ACA

May/June 2002 Issue (Volume 10, Issue 2)
Download the entire issue here or select individual articles below.

Highlights of the 9th Conference on Retroviruses and Opportunistic Infections:

HIV Pathogenesis and Vaccine Development
R. Paul Johnson, MD, and Amitinder Kaur, MD

Special Contribution:

Drug Resistance Mutations in HIV-1
International AIDS Society–USA Drug Resistance Mutations Group

Perspectives:

New Insights in HIV and Hepatitis C Virus Coinfection
Margaret J. Koziel, MD
Incomplete Viral Suppression Under Potent Antiretroviral Therapy: Determinants of Treatment Outcome
Steven G. Deeks, MD

Review:

The Potential Role of Therapeutic Drug Monitoring in the Treatment of HIV Infection
John G. Gerber, MD, and Edward P. Acosta, PharmD

March/April 2002 Issue (Volume 10, Issue 1)
Download the entire issue here or select individual articles below.

Highlights of the 9th Conference on Retroviruses and Opportunistic Infections:

Highlights of Basic Science Research
Mario Stevenson, MD
Complications of HIV Disease and Therapy
Judith S. Currier, MD, and Diane V. Havlir, MD
Management of Antiretroviral Therapy
Timothy J. Wilkin, MD, C. Mhorag Hay, MD, Christine M. Hogan, MD, and Scott M. Hammer, MD

Perspectives:

Managing Treatment Failure
Daniel R. Kuritzkes, MD
Overview of Mitochondrial Toxicity of Nucleoside Reverse Transcriptase Inhibitors
Marshall J. Glesby, MD, PhD

Special Contribution:

Switching Antiretroviral Drugs for Treatment of Metabolic Complications in HIV-1 Infection: Summary of Selected Trials
Michael S. Saag, MD, William G. Powderly, MD, Morris Schambelan, MD, Constance A. Benson, MD, Andrew Carr, MD, Judith S. Currier, MD, Michael P. Dubé, MD, John G. Gerber, MD, Steven K. Grinspoon, MD, Carl Grunfeld, MD, PhD, Donald P. Kotler, MD, and Kathleen Mulligan, PhD

Return to Top